How do I install the Es Cushing Treatment Goals Overt Cs skill?

Run npx skillmds@latest add dromlakhani/es-cushing-treatment-goals-overt-cs in your terminal (requires Node.js), paste this page's agent-chat prompt into Claude, Cursor, or any MCP-connected agent, or download the SKILL.md file and copy it into your agent's skills directory.

Is Es Cushing Treatment Goals Overt Cs safe to use?

This skill has not completed SkillMD's automated safety review yet. Independent scanners report: SkillSpector: PASS, Skill Scanner: PASS. Capability flags: docs only. SkillMD never runs a skill's scripts for you; review the SKILL.md before installing.

Which AI agents work with Es Cushing Treatment Goals Overt Cs?

This skill is tagged as working with Claude Code, Claude.ai, OpenAI Codex. SKILL.md is an open format, so most agents that read a skills directory can load it too.

Is Es Cushing Treatment Goals Overt Cs free to use?

Yes. Installing skills from SkillMD is free, and the skill stays under its author's original license.

Who published Es Cushing Treatment Goals Overt Cs?

dromlakhani (@dromlakhani) published this skill. Their other Agent Skills are listed on their SkillMD profile.

Es Cushing Treatment Goals Overt Cs by dromlakhani

Name: Es Cushing Treatment Goals Overt Cs
Rating: 4.2 (5 reviews)
Author: dromlakhani

Es Cushing Treatment Goals Overt Cs

This skill defines the treatment goals for patients with overt Cushing's syndrome, focusing on normalizing cortisol levels or action to eliminate symptoms and treat comorbidities. Use when a clinician asks about treatment objectives for a newly diagnosed overt Cushing's syndrome patient; triggers include "overt CS," "treatment goals for overt Cushing's," and "normalize cortisol in overt CS."

dromlakhani Updated Sep 8, 2026 10 repo stars

File contents

Treatment Goals for Overt Cushing's Syndrome

STEP 1 — Gather Information

Confirm diagnosis of overt Cushing's syndrome via clinical features (e.g., weight gain, hypertension, diabetes, skin changes) and biochemical tests (24‑h UFC > upper limit of normal, late‑night salivary cortisol > normal, or abnormal dexamethasone suppression test). Assess baseline comorbidities (hypertension, diabetes, dyslipidemia, osteoporosis, psychiatric symptoms) and current medications.

STEP 2 — Rule In / Rule Out

Rule in overt CS if biochemical hypercortisolism is present with specific signs/symptoms; rule out if only borderline biochemical abnormality of the HPA axis without any clinical manifestations of CS, as treatment is not recommended in that setting.

STEP 3 — Classify or Stratify

Classify postoperative or pretreatment cortisol status as hypercortisolemic (persistent elevated UFC or late‑night cortisol), eucortisolism (normal cortisol), or hypocortisolemic (low cortisol with symptoms of adrenal insufficiency). Persistent hypercortisolism after initial therapy indicates need for additional intervention.

STEP 4 — Decide

If hypercortisolism persists, initiate additional treatments (medical therapy, bilateral adrenalectomy, repeat transsphenoidal surgery, or radiation) aimed at normalizing cortisol; if eucortisolism is achieved, maintain cortisol normalization, treat comorbidities, and schedule lifelong surveillance for recurrence.

Clinical Guardrails / Mimics / Pitfalls

Do not treat based solely on borderline biochemical abnormalities without clinical signs; avoid overtreatment that may cause iatrogenic adrenal insufficiency; monitor for glucocorticoid withdrawal symptoms after surgery; address cortisol‑dependent comorbidities aggressively even when cortisol is normalized.

Concrete Clinical Example

A 48‑year‑man presents with progressive weight gain, new‑onset hypertension, and uncontrolled diabetes; 24‑h UFC is 6× ULN and late‑night salivary cortisol is elevated. Diagnosis of overt corticotropin‑secreting pituitary adenoma is confirmed. Treatment goal: normalize cortisol via transsphenoidal surgery, control hypertension and diabetes with adjunctive meds, and monitor postoperative cortisol and symptoms for remission.

Source: Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI:10.1210/jc.2015-1818

---name: es-cushing-treatment-goals-overt-csdescription: This skill defines the treatment goals for patients with overt Cushing's syndrome, focusing on normalizing cortisol levels or action to eliminate symptoms and treat comorbidities. Use when a clinician asks about treatment objectives for a newly diagnosed overt Cushing's syndrome patient; triggers include "overt CS," "treatment goals for overt Cushing's," and "normalize cortisol in overt CS."---# Treatment Goals for Overt Cushing's Syndrome## STEP 1 — Gather InformationConfirm diagnosis of overt Cushing's syndrome via clinical features (e.g., weight gain, hypertension, diabetes, skin changes) and biochemical tests (24‑h UFC > upper limit of normal, late‑night salivary cortisol > normal, or abnormal dexamethasone suppression test). Assess baseline comorbidities (hypertension, diabetes, dyslipidemia, osteoporosis, psychiatric symptoms) and current medications.## STEP 2 — Rule In / Rule OutRule in overt CS if biochemical hypercortisolism is present with specific signs/symptoms; rule out if only borderline biochemical abnormality of the HPA axis without any clinical manifestations of CS, as treatment is not recommended in that setting.## STEP 3 — Classify or StratifyClassify postoperative or pretreatment cortisol status as hypercortisolemic (persistent elevated UFC or late‑night cortisol), eucortisolism (normal cortisol), or hypocortisolemic (low cortisol with symptoms of adrenal insufficiency). Persistent hypercortisolism after initial therapy indicates need for additional intervention.## STEP 4 — DecideIf hypercortisolism persists, initiate additional treatments (medical therapy, bilateral adrenalectomy, repeat transsphenoidal surgery, or radiation) aimed at normalizing cortisol; if eucortisolism is achieved, maintain cortisol normalization, treat comorbidities, and schedule lifelong surveillance for recurrence.## Clinical Guardrails / Mimics / PitfallsDo not treat based solely on borderline biochemical abnormalities without clinical signs; avoid overtreatment that may cause iatrogenic adrenal insufficiency; monitor for glucocorticoid withdrawal symptoms after surgery; address cortisol‑dependent comorbidities aggressively even when cortisol is normalized.## Concrete Clinical ExampleA 48‑year‑man presents with progressive weight gain, new‑onset hypertension, and uncontrolled diabetes; 24‑h UFC is 6× ULN and late‑night salivary cortisol is elevated. Diagnosis of overt corticotropin‑secreting pituitary adenoma is confirmed. Treatment goal: normalize cortisol via transsphenoidal surgery, control hypertension and diabetes with adjunctive meds, and monitor postoperative cortisol and symptoms for remission.**Source:** Treatment of Cushing’s Syndrome: An Endocrine Society Clinical Practice Guideline, Nieman et al., 2015, DOI:10.1210/jc.2015-1818

Frequently asked questions